Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Constantinescu

Showing results (61-70 of 230) with videos related to

Pageof 23
Sort By:
Journal of Cellular and Molecular Medicine|September 4, 2013
Therapy targets in glioblastoma and cancer stem cells: lessons from haematopoietic neoplasmsMaria Linda Cruceru, Monica Neagu, Jean-Baptiste Demoulin, et al.
Plos One|June 30, 2010
JAK2 V617F constitutive activation requires JH2 residue F595: a pseudokinase domain target for specific inhibitorsAlexandra Dusa, Céline Mouton, Christian Pecquet, et al.
Molecular Cell|March 10, 2001
The erythropoietin receptor cytosolic juxtamembrane domain contains an essential, precisely oriented, hydrophobic motifS N Constantinescu, L J Huang, H Nam, et al.
Blood Reviews|July 15, 2020
A p53-JAK-STAT connection involved in myeloproliferative neoplasm pathogenesis and progression to secondary acute myeloid leukemiaHarsh Goyal, Ilyas Chachoua, Christian Pecquet, et al.
Biochemical Society Transactions|July 19, 2013
Activating Janus kinase pseudokinase domain mutations in myeloproliferative and other blood cancersStefan N Constantinescu, Emilie Leroy, Vitalina Gryshkova, et al.
Trends in Molecular Medicine|November 8, 2005
A JAK2 mutation in myeloproliferative disorders: pathogenesis and therapeutic and scientific prospectsChloé James, Valérie Ugo, Nicole Casadevall, et al.
Revue Roumaine De Virologie (Bucharest, Romania : 1990)|July 1, 1993
Neuroophthalmological examination in children with AIDSA F Constantinescu, S M Ruţă, S N Constantinescu, et al.
The Journal of Biological Chemistry|May 6, 2008
The Stat3-activating Tyk2 V678F mutant does not up-regulate signaling through the type I interferon receptor but confers ligand hypersensitivity to a homodimeric receptorMilica Gakovic, Josiane Ragimbeau, Véronique Francois, et al.
Frontiers in Endocrinology|April 15, 2017
The Thrombopoietin Receptor: Structural Basis of Traffic and Activation by Ligand, Mutations, Agonists, and Mutated CalreticulinLeila N Varghese, Jean-Philippe Defour, Christian Pecquet, et al.
Revista De Chirurgie, Oncologie, Radiologie, O.R.L., Oftalmologie, Stomatologie. Chirurgie|July 1, 1977
[Pulmonary resuscitation therapy in some forms of acute renal failure complicated by pulmonary diseases]F Purcaru, N Constantinescu, A Roşca, et al.
Pageof 23

Showing results (61-70 of 230) with videos related to

Sort By:
Pageof 23
Journal of Cellular and Molecular Medicine|September 4, 2013
Therapy targets in glioblastoma and cancer stem cells: lessons from haematopoietic neoplasmsMaria Linda Cruceru, Monica Neagu, Jean-Baptiste Demoulin, et al.
Plos One|June 30, 2010
JAK2 V617F constitutive activation requires JH2 residue F595: a pseudokinase domain target for specific inhibitorsAlexandra Dusa, Céline Mouton, Christian Pecquet, et al.
Molecular Cell|March 10, 2001
The erythropoietin receptor cytosolic juxtamembrane domain contains an essential, precisely oriented, hydrophobic motifS N Constantinescu, L J Huang, H Nam, et al.
Blood Reviews|July 15, 2020
A p53-JAK-STAT connection involved in myeloproliferative neoplasm pathogenesis and progression to secondary acute myeloid leukemiaHarsh Goyal, Ilyas Chachoua, Christian Pecquet, et al.
Biochemical Society Transactions|July 19, 2013
Activating Janus kinase pseudokinase domain mutations in myeloproliferative and other blood cancersStefan N Constantinescu, Emilie Leroy, Vitalina Gryshkova, et al.
Trends in Molecular Medicine|November 8, 2005
A JAK2 mutation in myeloproliferative disorders: pathogenesis and therapeutic and scientific prospectsChloé James, Valérie Ugo, Nicole Casadevall, et al.
Revue Roumaine De Virologie (Bucharest, Romania : 1990)|July 1, 1993
Neuroophthalmological examination in children with AIDSA F Constantinescu, S M Ruţă, S N Constantinescu, et al.
The Journal of Biological Chemistry|May 6, 2008
The Stat3-activating Tyk2 V678F mutant does not up-regulate signaling through the type I interferon receptor but confers ligand hypersensitivity to a homodimeric receptorMilica Gakovic, Josiane Ragimbeau, Véronique Francois, et al.
Frontiers in Endocrinology|April 15, 2017
The Thrombopoietin Receptor: Structural Basis of Traffic and Activation by Ligand, Mutations, Agonists, and Mutated CalreticulinLeila N Varghese, Jean-Philippe Defour, Christian Pecquet, et al.
Revista De Chirurgie, Oncologie, Radiologie, O.R.L., Oftalmologie, Stomatologie. Chirurgie|July 1, 1977
[Pulmonary resuscitation therapy in some forms of acute renal failure complicated by pulmonary diseases]F Purcaru, N Constantinescu, A Roşca, et al.
Pageof 23